Lilly Warns of Health Risks from Impurity in Compounded Weight-Loss Drug

Pharmaceutical company finds issue with unauthorized version of its medication.

Mar. 13, 2026 at 11:49am

Got story updates? Submit your updates here. ›

Eli Lilly and Company has discovered an impurity in a compounded version of its weight-loss drug that contains vitamin B12 and the main ingredient in Lilly's medication. The pharmaceutical giant is warning the public about potential health risks associated with using this unauthorized formulation.

Why it matters

Compounded drugs that are not properly regulated can pose serious safety concerns for consumers. This issue highlights the importance of only using FDA-approved medications from reputable manufacturers to avoid potential contamination or other problems.

The details

Lilly said it found the impurity in a compounded version of its weight-loss drug that was being produced and distributed without the company's authorization. The compounded drug contained the active ingredient in Lilly's medication as well as vitamin B12. Lilly did not specify what the impurity was or provide details on any potential health risks, but warned that use of the unauthorized product could lead to adverse effects.

  • Lilly discovered the impurity in the compounded drug on March 10, 2026.

The players

Eli Lilly and Company

A major pharmaceutical company that manufactures prescription drugs, including a weight-loss medication.

Got photos? Submit your photos here. ›

What they’re saying

“We are warning the public about this compounded product to protect patient safety.”

— Lilly spokesperson

What’s next

Lilly said it is working with the FDA and law enforcement to investigate the source of the compounded drug and stop its distribution.

The takeaway

This incident underscores the importance of only using FDA-approved medications from reputable pharmaceutical companies, as compounded drugs that bypass regulatory oversight can pose serious health risks to consumers.